Elucidating cellular mechanisms underlying neurodegeneration
阐明神经变性的细胞机制
基本信息
- 批准号:10435954
- 负责人:
- 金额:$ 57.57万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-06-17 至 2027-05-31
- 项目状态:未结题
- 来源:
- 关键词:Adaptor Signaling ProteinAdolescentAlzheimer&aposs DiseaseAmino AcidsAntisense OligonucleotidesAutophagocytosisAutophagosomeAxonAxonal TransportBehavioralCell Culture TechniquesCell NucleusCell physiologyCellsClinicComplexDataDegradation PathwayDiseaseEnvironmentEventExcisionFamilyFunctional disorderFutureGenesGoalsImpairmentIntermediate FilamentsIntracellular TransportKnock-outKnockout MiceLightLysosomesMediatingMitochondriaModelingMovementMusMutateMutationNamesNerve DegenerationNeuritesNeurodegenerative DisordersNeurologic SymptomsNeuronsOrganellesParkinson DiseasePathogenesisPathologicPathologyPathway interactionsPeripheral Nervous SystemPhenotypePhosphorylationPlayProcessProteinsProteomicsQuality ControlRegulationReportingResearchRoleSeveritiesShapesSignal PathwaySignal TransductionSirolimusSiteSpinal GangliaStable Isotope LabelingTestingUbiquitinUbiquitinationanalogbasecell typeearly onsetexperimental studygiant axonal neuropathygigaxoninloss of function mutationmembermulticatalytic endopeptidase complexnervous system disorderneurofilamentneuropathologynovelprotein degradationsmall hairpin RNAsmall moleculetherapeutic targettherapy developmenttreatment strategyubiquitin ligaseubiquitin-protein ligase
项目摘要
Giant axonal neuropathy (GAN) is an early-onset, autosomal recessive neurodegenerative disease that
impacts the central and peripheral nervous systems. Pathologically, GAN is characterized by the
disorganization and aggregation of intermediate filaments (IF). Formed from self-assembling subunits, the IF
network spans the cell from the nucleus to the periphery. In GAN, many cell types show abnormalities in the
organization of IF, but neurons clearly bear the brunt of the pathology. Axons swell with the accumulation of
neuronal IF, and degenerate to cause the neurological symptoms of GAN. The gene mutated in GAN encodes
gigaxonin, a protein that belongs to the BTB/Kelch family of E3 ligase-like adaptor proteins. These proteins
typically play a role in ubiquitin-proteasome mediated protein degradation. Based on our own data that GAN
degrades neuronal IFs, we hypothesize that neurofilament aggregation creates steric roadblocks in neurites
that interfere with intracellular transport of organelles such as mitochondria and lysosomes, resulting in
downstream pathology. Furthermore, our preliminary data suggest gigaxonin plays a direct role in autophagy
via degradation of other substrates. We hypothesize that the disruption of this critical process exacerbates
GAN neuropathology by dysregulation of protein and organellar quality control. This proposal comprehensively
tests these models; thus the overall goal of our research is to understand the cellular pathogenesis of GAN
with a view to inspiring novel treatment strategies.
巨型轴突神经病(GAN)是一种早期发作的常染色体隐性神经退行性疾病,
影响中央和周围神经系统。从病理上讲,甘的特征是
中间细丝的混乱和聚集(如果)。由自组装亚基形成
网络跨越细胞从细胞核到周围。在GAN中,许多细胞类型在
IF的组织,但神经元显然是病理的首当其冲。轴突随着积累的积累而膨胀
神经元IF并退化会引起GAN的神经系统症状。 GAN编码中突变的基因
Gigaxonin,一种属于E3连接酶样衔接蛋白的BTB/Kelch家族的蛋白质。这些蛋白质
通常在泛素 - 蛋白酶体介导的蛋白质降解中起作用。基于我们自己的数据
降解神经元IF,我们假设神经丝聚集在神经突中产生空间障碍
干扰细胞内细胞器(例如线粒体和溶酶体)的细胞内转运,导致
下游病理。此外,我们的初步数据表明,千兆蛋白在自噬中起着直接的作用
通过其他底物的降解。我们假设这一关键过程的破坏加剧了
蛋白质和细胞器质量控制失调的GAN神经病理学。该建议全面
测试这些模型;因此,我们研究的总体目标是了解GAN的细胞发病机理
为了鼓舞新的治疗策略。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Puneet Opal其他文献
Puneet Opal的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Puneet Opal', 18)}}的其他基金
VEGF-Mimetic Supramolecular Nanoparticles for Treating Spinocerebellar Ataxia Type 1
VEGF 模拟超分子纳米颗粒用于治疗 1 型脊髓小脑共济失调
- 批准号:
10578485 - 财政年份:2023
- 资助金额:
$ 57.57万 - 项目类别:
Equipment Supplement: Understanding the Cellular Basis of Movement Disorders
设备补充:了解运动障碍的细胞基础
- 批准号:
10755946 - 财政年份:2023
- 资助金额:
$ 57.57万 - 项目类别:
Elucidating cellular mechanisms underlying neurodegeneration
阐明神经变性的细胞机制
- 批准号:
10647869 - 财政年份:2022
- 资助金额:
$ 57.57万 - 项目类别:
Developing novel treatment strategies for Spinocerebellar ataxia type 1
开发 1 型脊髓小脑共济失调的新治疗策略
- 批准号:
9226821 - 财政年份:2016
- 资助金额:
$ 57.57万 - 项目类别:
Understanding the cellular basis of Movement Disorders
了解运动障碍的细胞基础
- 批准号:
8876831 - 财政年份:2013
- 资助金额:
$ 57.57万 - 项目类别:
Understanding the cellular basis of Movement Disorders
了解运动障碍的细胞基础
- 批准号:
8631893 - 财政年份:2013
- 资助金额:
$ 57.57万 - 项目类别:
Understanding the Cellular Basis of Movement Disorders
了解运动障碍的细胞基础
- 批准号:
10630308 - 财政年份:2013
- 资助金额:
$ 57.57万 - 项目类别:
Understanding the Cellular Basis of Movement Disorders
了解运动障碍的细胞基础
- 批准号:
10403448 - 财政年份:2013
- 资助金额:
$ 57.57万 - 项目类别:
Understanding the cellular basis of Movement Disorders
了解运动障碍的细胞基础
- 批准号:
8719191 - 财政年份:2013
- 资助金额:
$ 57.57万 - 项目类别:
Understanding the Cellular Basis of Movement Disorders
了解运动障碍的细胞基础
- 批准号:
10160963 - 财政年份:2013
- 资助金额:
$ 57.57万 - 项目类别:
相似国自然基金
青少年肌阵挛性癫痫发作控制与复发的脑网络系统动力稳定性大时间尺度演化机制研究
- 批准号:82301640
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
心肺耐力对青少年执行功能影响效应及其特定脑区激活状态的多民族研究
- 批准号:82373595
- 批准年份:2023
- 资助金额:47 万元
- 项目类别:面上项目
中国父母情绪教养行为对青少年非自杀性自伤的影响及其机制
- 批准号:32300894
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
执行技能训练联合动机行为治疗对注意缺陷多动障碍青少年疗效及脑机制
- 批准号:82371557
- 批准年份:2023
- 资助金额:65 万元
- 项目类别:面上项目
自然接触对青少年网络问题行为的作用机制及其干预
- 批准号:72374025
- 批准年份:2023
- 资助金额:40 万元
- 项目类别:面上项目
相似海外基金
Elucidating cellular mechanisms underlying neurodegeneration
阐明神经变性的细胞机制
- 批准号:
10647869 - 财政年份:2022
- 资助金额:
$ 57.57万 - 项目类别:
Regulation of hippocampal morphogenesis and homeostasis by the E3 ubiquitin ligase CRL5
E3 泛素连接酶 CRL5 对海马形态发生和稳态的调节
- 批准号:
10089489 - 财政年份:2019
- 资助金额:
$ 57.57万 - 项目类别:
Regulation of hippocampal morphogenesis and homeostasis by the E3 ubiquitin ligase CRL5
E3 泛素连接酶 CRL5 对海马形态发生和稳态的调节
- 批准号:
10557808 - 财政年份:2019
- 资助金额:
$ 57.57万 - 项目类别:
Regulation of hippocampal morphogenesis and homeostasis by the E3 ubiquitin ligase CRL5
E3 泛素连接酶 CRL5 对海马形态发生和稳态的调节
- 批准号:
9814602 - 财政年份:2019
- 资助金额:
$ 57.57万 - 项目类别:
Regulation of hippocampal morphogenesis and homeostasis by the E3 ubiquitin ligase CRL5
E3 泛素连接酶 CRL5 对海马形态发生和稳态的调节
- 批准号:
10337130 - 财政年份:2019
- 资助金额:
$ 57.57万 - 项目类别: